IMPACCT: RWE – Real World Evidence Conference

By Visited 97 times , 1 Visits today

Start Date: 2018-09-25
End Date: 2018-09-27
Time: 8:00 am to 5:00 pm

Phone: +1 617 455 4188

Location: Hilton Boston/Woburn, 2 Forbes Road, Woburn 01801, United States


Get Direction View Large Map


If you’re actively invested in leveraging evidence to support drug development and commercialization, join the 6th annual IMPACCT:RWE 2018 meeting, where you will have an opportunity to explore how RWE is currently applied across the drug development continuum to support decision-making in clinical development, drug marketing and commercialization.

Today more than ever, we live in a world of mobile, digital and electronic generated data. In healthcare, real-world data provide great potential for better design and conduct of clinical trials and generate more value-based outcomes in drug development. To gain competitive advantage and achieve better outcomes, pharma and biotech organizations seek to advance the way they use RWE – real-world evidence, for the benefit of patients and commercial success of their products.

Key Reasons to attend:

1. Discover how to innovate the use of the available real-world data, and translate it into clinically meaningful effects in the real world and more evidence-based decision-making processes.

2. Share your learnings and perspectives with a focused community of industry peers.

3. Gain insight into how to plan the evidence generation to effectively support drug development and commercialization success, enhance decision making, and establish yourself as a value generating organization.

4. Contribute to collaboratively advance the ‘impacct’ of RWE in drug development, patient-centricity, and product life-cycle.

5. Learn how RWE can be applied across the drug development continuum, particularly in clinical development, drug marketing and commercialization stages.

Take a look at the full program to preview 18+ focused case studies, expert speaker line-up and attendance breakdown::


Conference Only: USD 2499.0
Conference Plus Workshop: USD 2998.0
Workshop Only: USD 599.0

Speakers: Ann Hartry, VP, US HEOR & RWE, Lundbeck, Kourtney Davis, Senior Director & Global Head of RWD & Analytics, GSK, Christoph Koenen, Head of Cardiovascular Development, Therapeutic Area Head, BMS, Shanthy Krishnarajah, Senior Director, Global Health Economics & Reimbursement Strategy, CSL Behring, Frank Zhang, VP Market Access – Global Strategy & US, Alnylam Pharmaceuticals, Melvin “Skip” Olson, Global Head Real World Data Strategy & Innovation, Novartis, Carl de Moor, Senior Director & Head of Global RWE Strategy, Analytics & Biostatistics, Biogen


Organized by :  HansonWade Email : [email protected]

Contact the Organizer

About the Organizers :

How to Register

Click on the below link to register by going to our website.

Comments are closed.

Related Events